×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

TG Therapeutics Inc. (TGTX) NASDAQ

$7.75 (0.21) (-2.64%)

Market Cap: $1.20B

As of 10/04/23 04:00 PM EDT. Market closed.

(TGTX)

TG Therapeutics Inc. (TGTX)
NASDAQ

$7.75
(0.21) (-2.64%)

Market Cap: $1.20B

As of 10/04/23 04:00 PM EDT. Market closed.

tg therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for b-cell malignancies and autoimmune diseases. currently, the company is developing two therapies targeting hematological malignancies. tg-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a specific and unique epitope on the cd20 antigen ... read more

tg therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for b-cell malignancies and autoimmune diseases. currently, the company is developing two therapies targeting hematological malignancies. tg-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a specific and unique epitope on the cd20 antigen found on mature b-lymphocytes. tg therapeutics is also developing tgr-1202, an orally available pi3k delta inhibitor. the delta isoform of pi3k is strongly expressed in cells of hematopoietic origin and is believed to be important in the proliferation and survival of b-lymphocytes. both tg-1101 and tgr-1202 are in clinical development for patients with hematologic malignancies. the company also has pre-clinical programs to develop irak4 inhibitors, and anti-pd-l1 and anti-gitr antibodies. tg therapeutics is headquartered in new york city and is traded on nasdaq under the ticker symbol "tgtx". read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Weiss
Full Time Employees
276
CEO Compensation (Base)
$655,625
CEO Compensation (Total)
$14.30M
URL
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Weiss
Full Time Employees
276
CEO Compensation (Base)
$655,625
CEO Compensation (Total)
$14.30M
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
PRICE CHART FOR TG THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$7.87
Previous Close
$7.96
Days Range
$7.72 - $7.94
52 week range
$4.86 - $35.67
Volume
2,261,823
Avg. Volume (30 days)
4,083,922
Market Cap
$1.20B
Dividend Yield
-
P/E
(6.84)
Shares Outstanding
150,977,564
Open
$7.87
Previous Close
$7.96
Days Range
$7.72 - $7.94
52 week range
$4.86 - $35.67
Volume
2,261,823
Avg. Volume (30 days)
4,083,922
Market Cap
$1.20B
Dividend Yield
-
P/E
(6.84)
Shares Outstanding
150,977,564
FINANCIAL STATEMENTS FOR TG THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TG THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
WEISS MICHAEL SCEO and PresidentAug 11, 2023 Buy$10.13100,0001,013,00012,073,021Aug 14, 2023, 09:54 AM
Lonial SagarDirectorJun 23, 2023 Sale$23.3734,854814,53893,878Jun 26, 2023, 05:00 PM
Power Sean AChief Financial OfficerJun 02, 2023 Sale$26.7073,6471,966,375654,836Jun 05, 2023, 06:26 PM
Echelard YannDirectorJan 06, 2023 Buy$10.649,00095,760201,848Jan 06, 2023, 05:01 PM
Charney Laurence NDirectorJan 04, 2023 Sale$11.1030,000333,000234,729Jan 06, 2023, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJan 05, 2022 Sale$18.319,653176,746568,483Jan 07, 2022, 06:11 PM
Power Sean ACFO, Secretary and TreasurerJan 04, 2022 Sale$19.2075,3121,445,990578,136Jan 07, 2022, 06:11 PM
WEISS MICHAEL SCEO and PresidentJan 05, 2022 Sale$18.3130,671561,58610,988,021Jan 07, 2022, 06:00 PM
WEISS MICHAEL SCEO and PresidentJan 04, 2022 Sale$19.2037,549720,94113,455,697Jan 07, 2022, 06:00 PM
Echelard YannDirectorDec 10, 2020 Sale$40.0530,0001,201,500129,116Dec 11, 2020, 05:01 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerSep 09, 2020 Sale$25.81158,5894,092,73812,629,868Sep 11, 2020, 04:31 PM
KENNEDY WILLIAM JAMESDirectorJun 17, 2020 Sale$18.277,745141,50194,633Jun 24, 2020, 07:48 PM
Power Sean ACFO, Secretary and TreasurerJul 01, 2019 Sale$8.4717,654149,529383,338Jul 03, 2019, 04:00 PM
WEISS MICHAEL SCEO and PresidentJun 26, 2019 Buy$7.0350,000351,75012,878,185Jun 27, 2019, 07:33 AM
Power Sean ACFO, Secretary and TreasurerJan 02, 2019 Sale$4.1337,275153,946400,992Jan 03, 2019, 07:21 PM
Power Sean ACFO, Secretary and TreasurerJul 03, 2018 Sale$13.1935,000461,650438,267Jul 05, 2018, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJul 02, 2018 Sale$13.2612,191161,653473,267Jul 05, 2018, 05:00 PM
KENNEDY WILLIAM JAMESDirectorJun 14, 2018 Sale$13.4525,071337,20560,330Jun 18, 2018, 04:30 PM
Power Sean ACFO, Secretary and TreasurerJan 02, 2018 Sale$8.5032,006272,051485,458Jan 03, 2018, 05:25 PM
Power Sean ACFO, Secretary and TreasurerJun 16, 2017 Sale$11.1429,976333,933477,464Jun 19, 2017, 06:05 PM
Power Sean ACFO, Secretary and TreasurerJun 19, 2017 Sale$11.0430,000331,200447,464Jun 19, 2017, 06:05 PM
KENNEDY WILLIAM JAMESDirectorApr 11, 2017 Sale$10.278,54887,78870,401Apr 12, 2017, 05:44 PM
Charney Laurence NDirectorApr 04, 2017 Sale$11.177,00078,19088,949Apr 04, 2017, 05:57 PM
Power Sean ACFO, Secretary and TreasurerJan 04, 2017 Sale$4.558,81640,113507,440Jan 04, 2017, 05:28 PM
Power Sean ACFO, Secretary and TreasurerJul 05, 2016 Sale$5.9950,426302,052416,256Jul 08, 2016, 08:06 PM
Power Sean ACFO, Secretary and TreasurerApr 18, 2016 Sale$10.1210,000101,200466,682Apr 20, 2016, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJan 05, 2016 Sale$11.2122,790255,476476,682Jan 07, 2016, 06:00 PM
KENNEDY WILLIAM JAMESDirectorJul 08, 2015 Sale$17.0817,000290,36066,490Jul 09, 2015, 09:41 PM
Power Sean ACFO, Secretary and TreasurerJul 01, 2015 Sale$16.4650,054823,889449,472Jul 02, 2015, 05:00 PM
LFB Biotechnologies S.A.S.U.10% OwnerFeb 17, 2015 Buy$6.53114,855750,0035,114,855May 11, 2015, 04:30 PM
LFB Biotechnologies S.A.S.U.10% OwnerMay 07, 2015 Option Exercise$0.002,500,0002,5007,614,855May 11, 2015, 04:30 PM
Power Sean ACFO, Secretary and TreasurerApr 02, 2015 Sale$15.5111,000170,610499,526Apr 03, 2015, 05:00 PM
Power Sean ACFO, Secretary and TreasurerApr 01, 2015 Sale$15.5012,800198,400510,526Apr 03, 2015, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJan 07, 2015 Sale$16.4012,344202,442523,326Jan 07, 2015, 08:50 PM
Power Sean ACFO, Secretary and TreasurerJan 05, 2015 Sale$16.4054,057886,448535,670Jan 07, 2015, 08:50 PM
WEISS MICHAEL SSee RemarksDec 16, 2014 Sale$16.44210,6183,462,5608,120,773Dec 18, 2014, 09:44 PM
Power Sean ACFO, Secretary and TreasurerDec 16, 2014 Sale$16.4438,041625,394579,727Dec 18, 2014, 09:37 PM
Power Sean ACFO, Secretary and TreasurerNov 21, 2013 Option Exercise$5.3823,106124,310542,768Jan 02, 2014, 07:00 PM
WEISS MICHAEL SSee RemarksDec 11, 2013 Buy$3.4310,00034,3007,839,471Dec 12, 2013, 06:06 AM
Power Sean ACFO, Secretary and TreasurerMay 17, 2012 Option Exercise$6.2513,52684,538490,874Jan 02, 2013, 08:11 PM
Herskowitz NeilDirectorDec 06, 2012 Buy$2.001,0002,00051,265Dec 12, 2012, 04:30 PM
Power Sean ACFO, Secretary and TreasurerSep 14, 2012 Buy$2.283,4007,752504,400Sep 17, 2012, 09:46 AM
Power Sean ACFO, Secretary and TreasurerSep 13, 2012 Buy$2.251,0002,250501,000Sep 17, 2012, 09:46 AM
WEISS MICHAEL SSee RemarksSep 11, 2012 Buy$2.25100,000225,0007,342,728Sep 11, 2012, 04:01 PM
WEISS MICHAEL SSee RemarksSep 10, 2012 Buy$2.2550,000112,5007,242,728Sep 11, 2012, 04:01 PM
WEISS MICHAEL SSee RemarksMay 16, 2012 Buy$6.251,5009,3755,192,728May 17, 2012, 05:32 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
WEISS MICHAEL SCEO and President08/11/20231,013,000
Lonial SagarDirector06/23/2023814,538
Power Sean AChief Financial Officer06/02/20231,966,375
Echelard YannDirector01/06/202395,760
Charney Laurence NDirector01/04/2023333,000
Power Sean ACFO, Secretary and Treasurer01/05/2022176,746
Power Sean ACFO, Secretary and Treasurer01/04/20221,445,990
WEISS MICHAEL SCEO and President01/05/2022561,586
WEISS MICHAEL SCEO and President01/04/2022720,941
Echelard YannDirector12/10/20201,201,500
RA CAPITAL MANAGEMENT, L.P.10% Owner09/09/20204,092,738
KENNEDY WILLIAM JAMESDirector06/17/2020141,501
Power Sean ACFO, Secretary and Treasurer07/01/2019149,529
WEISS MICHAEL SCEO and President06/26/2019351,750
Power Sean ACFO, Secretary and Treasurer01/02/2019153,946
Power Sean ACFO, Secretary and Treasurer07/03/2018461,650
Power Sean ACFO, Secretary and Treasurer07/02/2018161,653
KENNEDY WILLIAM JAMESDirector06/14/2018337,205
Power Sean ACFO, Secretary and Treasurer01/02/2018272,051
Power Sean ACFO, Secretary and Treasurer06/16/2017333,933
Power Sean ACFO, Secretary and Treasurer06/19/2017331,200
KENNEDY WILLIAM JAMESDirector04/11/201787,788
Charney Laurence NDirector04/04/201778,190
Power Sean ACFO, Secretary and Treasurer01/04/201740,113
Power Sean ACFO, Secretary and Treasurer07/05/2016302,052
Power Sean ACFO, Secretary and Treasurer04/18/2016101,200
Power Sean ACFO, Secretary and Treasurer01/05/2016255,476
KENNEDY WILLIAM JAMESDirector07/08/2015290,360
Power Sean ACFO, Secretary and Treasurer07/01/2015823,889
LFB Biotechnologies S.A.S.U.10% Owner02/17/2015750,003
LFB Biotechnologies S.A.S.U.10% Owner05/07/20152,500
Power Sean ACFO, Secretary and Treasurer04/02/2015170,610
Power Sean ACFO, Secretary and Treasurer04/01/2015198,400
Power Sean ACFO, Secretary and Treasurer01/07/2015202,442
Power Sean ACFO, Secretary and Treasurer01/05/2015886,448
WEISS MICHAEL SSee Remarks12/16/20143,462,560
Power Sean ACFO, Secretary and Treasurer12/16/2014625,394
Power Sean ACFO, Secretary and Treasurer11/21/2013124,310
WEISS MICHAEL SSee Remarks12/11/201334,300
Power Sean ACFO, Secretary and Treasurer05/17/201284,538
Herskowitz NeilDirector12/06/20122,000
Power Sean ACFO, Secretary and Treasurer09/14/20127,752
Power Sean ACFO, Secretary and Treasurer09/13/20122,250
WEISS MICHAEL SSee Remarks09/11/2012225,000
WEISS MICHAEL SSee Remarks09/10/2012112,500
WEISS MICHAEL SSee Remarks05/16/20129,375
Load More Insider Transactions
FUNDS WITH A POSITION IN TG THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.9,917,4630.00679%12.07%Other
GEODE CAPITAL MANAGEMENT, LLC2,830,5890.00826%5.63%Other
HOLOCENE ADVISORS, LP1,625,5890.17%NewGrowth At A Reasonable Price
D. E. SHAW & CO., INC.1,575,4710.04%88.96%Other
BALYASNY ASSET MANAGEMENT L.P.716,9640.04%101.82%Event Driven
RENAISSANCE TECHNOLOGIES LLC536,2000.02%NewOther
DRIEHAUS CAPITAL MANAGEMENT LLC363,8310.11%-57.08%Growth
GOTHAM ASSET MANAGEMENT, LLC130,6940.07%8.11%Other
AQR CAPITAL MANAGEMENT LLC63,6380.00336%46.71%Other
ORBIMED ADVISORS LLC45,800 (Call)0.02%NewOther
MAGNETAR FINANCIAL LLC43,0530.02%239.13%Event Driven, Other
D. E. SHAW & CO., INC.11,200 (Call)0.00028%NewOther
CHANGE IN SHARES OUTSTANDING FOR TG THERAPEUTICS INC
STOCK BUYBACKS FOR TG THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
0.85%
1Q
06/30/2023
12/31/2022
3.19%
2Q
06/30/2023
09/30/2022
4.56%
3Q
06/30/2023
06/30/2022
4.99%
4Q
06/30/2023
03/31/2022
5.29%
5Q
06/30/2023
12/31/2021
6.75%
6Q
06/30/2023
09/30/2021
6.91%
7Q
06/30/2023
06/30/2021
7.14%
8Q
06/30/2023
03/31/2021
7.28%
9Q
06/30/2023
12/31/2020
13.94%
10Q
06/30/2023
09/30/2020
18.73%
11Q
06/30/2023
06/30/2020
25.95%
12Q
06/30/2023
03/31/2020
34.18%
13Q
06/30/2023
12/31/2019
47.80%
14Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
0.85%
1Q
12/31/2022
3.19%
2Q
09/30/2022
4.56%
3Q
06/30/2022
4.99%
4Q
03/31/2022
5.29%
5Q
12/31/2021
6.75%
6Q
09/30/2021
6.91%
7Q
06/30/2021
7.14%
8Q
03/31/2021
7.28%
9Q
12/31/2020
13.94%
10Q
09/30/2020
18.73%
11Q
06/30/2020
25.95%
12Q
03/31/2020
34.18%
13Q
12/31/2019
47.80%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TG THERAPEUTICS INC
LOADING...